NCT03099408View on ClinicalTrials.gov

Oral Metronidazole With Lactobacillus Vaginal Suppositories to Prevent Recurrence of Bacterial Vaginosis

PHASE4CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

December 30, 2020

Study Completion Date

December 30, 2020

Conditions
Bacterial VaginosisRecurrence
Interventions
DRUG

Metronidazole Oral

Oral metronidazole 400 mg BID for 7 days at first month.

DRUG

"Metronidazole and Lactobacillus"

Oral metronidazole metronidazole 400 mg BID for 7 days at first month and Lactobacillus vaginal suppositories for 10 days at first month,second month and third month.

Trial Locations (1)

518036

Dept Obstetrics and Gynecology, Shenzhen

All Listed Sponsors
lead

Peking University Shenzhen Hospital

OTHER

NCT03099408 - Oral Metronidazole With Lactobacillus Vaginal Suppositories to Prevent Recurrence of Bacterial Vaginosis | Biotech Hunter | Biotech Hunter